FIS
FCPM III Services Portfolio holdings
AUM
$369M
This Quarter Return
-10.61%
1 Year Return
-29.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$369M
AUM Growth
+$369M
(-11%)
Cap. Flow
-$415K
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
RAPT Therapeutics
RAPT
|
$3.45M |
| 2 |
Astria Therapeutics
ATXS
|
$1.62M |
Top Sells
| 1 |
NewAmsterdam Pharma
NAMS
|
$5.49M |
Sector Composition
| 1 | Healthcare | 99.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NewAmsterdam Pharma
NAMS
$2.77B
| $193M | 52.16% |
10,632,113
-303,197
| -3% | -$5.49M |
|
2
Dyne Therapeutics
DYN
$1.92B
| $52M | 14.09% |
5,462,846
| – | – |
|
3
Replimune Group
REPL
$461M
| $36.3M | 9.84% |
3,909,696
| – | – |
|
4
enGene Holdings
ENGN
$245M
| $35.1M | 9.5% |
9,632,561
| – | – |
|
|
BCYC
5
Bicycle Therapeutics
BCYC
$499M
| $24M | 6.5% |
3,452,330
| – | – |
|
|
6
Astria Therapeutics
ATXS
$372M
| $23.4M | 6.34% |
4,107,537
+285,000
| +7% | +$1.62M |
|
|
7
RAPT Therapeutics
RAPT
$196M
| $3.45M | 0.93% |
+440,176
| New | +$3.45M |
|
|
8
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $2.36M | 0.64% |
2,878,148
| – | – |
|